- Home
- TMCI vs POET Comparison
TMCI vs POET Comparison
Compare TMCI & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMCI
- POET
- Stock Information
- Founded
- TMCI 2014
- POET 1972
- Country
- TMCI United States
- POET Canada
- Employees
- TMCI N/A
- POET N/A
- Industry
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- POET Semiconductors
- Sector
- TMCI Health Care
- POET Technology
- Exchange
- TMCI Nasdaq
- POET Nasdaq
- Market Cap
- TMCI 371.1M
- POET 366.1M
- IPO Year
- TMCI 2021
- POET N/A
- Fundamental
- Price
- TMCI $6.18
- POET $5.74
- Analyst Decision
- TMCI Hold
- POET Strong Buy
- Analyst Count
- TMCI 6
- POET 2
- Target Price
- TMCI $9.18
- POET $6.25
- AVG Volume (30 Days)
- TMCI 325.4K
- POET 1.9M
- Earning Date
- TMCI 08-05-2025
- POET 08-13-2025
- Dividend Yield
- TMCI N/A
- POET N/A
- EPS Growth
- TMCI N/A
- POET N/A
- EPS
- TMCI N/A
- POET N/A
- Revenue
- TMCI $210,819,000.00
- POET $199,477.00
- Revenue This Year
- TMCI $10.61
- POET $8,377.56
- Revenue Next Year
- TMCI $10.36
- POET $1,061.73
- P/E Ratio
- TMCI N/A
- POET N/A
- Revenue Growth
- TMCI 7.54
- POET N/A
- 52 Week Low
- TMCI $4.54
- POET $2.27
- 52 Week High
- TMCI $10.79
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- TMCI 55.03
- POET 73.94
- Support Level
- TMCI $5.54
- POET $4.94
- Resistance Level
- TMCI $6.24
- POET $5.94
- Average True Range (ATR)
- TMCI 0.31
- POET 0.39
- MACD
- TMCI 0.09
- POET 0.16
- Stochastic Oscillator
- TMCI 90.11
- POET 87.50
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.